America’s new drug-pricing rules have perverse consequences
The new drug-pricing rules in America, allowing Medicare to negotiate prices with drugmakers, could have damaging effects by setting prices too low and deterring innovation.
The new drug-pricing rules in America, allowing Medicare to negotiate prices with drugmakers, could have damaging effects by setting prices too low and deterring innovation.